# Clinical Trial of PCV24 in Infants Aged 2-23 Months

> **NCT06800261** · PHASE1 · RECRUITING · sponsor: **Sinovac Life Sciences Co., Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Pneumococcal Infectious Disease

## Interventions

- **BIOLOGICAL:** Sinovac PCV24
- **BIOLOGICAL:** Prevnar®

## Key facts

- **NCT ID:** NCT06800261
- **Lead sponsor:** Sinovac Life Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06800261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06800261, "Clinical Trial of PCV24 in Infants Aged 2-23 Months". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06800261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*